🇺🇸 FDA
Pipeline program

Tacrolimus

CR017827

Approved small_molecule completed

Quick answer

Tacrolimus for Dermatitis, Atopic is a Approved program (small_molecule) at Janssen-Cilag Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen-Cilag Pty Ltd
Indication
Dermatitis, Atopic
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials